2022
DOI: 10.1007/s11906-022-01204-6
|View full text |Cite
|
Sign up to set email alerts
|

Is Vitamin D Supplementation an Effective Treatment for Hypertension?

Abstract: Purpose of the Review Results from epidemiological studies suggest that vitamin D (VD) deficiency (VDD) may be a cause of hypertension (HTN). However, the results of randomized clinical trials (RCTs) designed to address the impact of VD supplementation on reducing blood pressure (BP) remain equivocal. To determine whether VD might serve as a beneficial treatment option for a specific subset of hypertensive patients, we performed a stratified analysis of RCT data and addressed problems associated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 84 publications
0
2
0
Order By: Relevance
“…In literature, recommended therapeutic intervention for the treatment of hypertension is vitamin D replacement. 22 As a result, vitamin D concentrations of Alzheimer's patients should be closely monitored and supplementation should be given as soon as a deficiency is detected.…”
Section: Discussionmentioning
confidence: 99%
“…In literature, recommended therapeutic intervention for the treatment of hypertension is vitamin D replacement. 22 As a result, vitamin D concentrations of Alzheimer's patients should be closely monitored and supplementation should be given as soon as a deficiency is detected.…”
Section: Discussionmentioning
confidence: 99%
“…However, the efficacy of vitamin supplementation for reducing blood pressure in patients with hypertension remains unclear. Differences in the populations tested, doses of intervention and duration of intervention could result in different trial outcomes 9 10. Meta-analysis could provide strong evidence to inform clinical decision-making by integrating and analysing existing trial data.…”
Section: Introductionmentioning
confidence: 99%